Form 4 for BAX Baxter International
Accepted 2024-03-08 00:00:00 ET · period of report 2024-03-06 · accession 0001062993-24-005959 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-08 | 2024-03-06 | BAX | Knight Heather | EVP, Group Pres, Med Products | A - Grant | $0.00 | +107.2K | 160.3K | +202% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $1 par value | 2024-03-06 | A | A | 107,168 | $0.00 | 160,330 | D | — | — | (F1) For 2024, the annual equity grant for the reporting person consisted solely of restricted stock units (RSUs). The reporting person received a grant of RSUs which are scheduled to vest in three equal annual installments beginning on March 6, 2025, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2021 Incentive Plan. |